Next Article in Journal
Nutrition, Physical Activity, and Dietary Supplementation to Prevent Bone Mineral Density Loss: A Food Pyramid
Previous Article in Journal
Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 14
Issue 1
10.3390/nu14010077
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Coping Strategies Influence Cardiometabolic Risk Factors in Chronic Psychological Stress: A Post Hoc Analysis of A Randomized Pilot Study

by
Deborah Armborst
1,*,
Norman Bitterlich
2,
Birgit Alteheld
3,
Daniela Rösler
4,
Christine Metzner
4,5,† and
Roswitha Siener
1,†
1
Department of Urology, Medical Nutrition Science, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany
2
Department of Biostatistics, Medicine and Service Ltd., Boettcherstr. 10, 09117 Chemnitz, Germany
3
Department of Nutrition and Food Sciences, Nutritional Physiology, University of Bonn, Nussallee 9, 53115 Bonn, Germany
4
Bonn Education Association for Dietetics r. A., Fuerst-Pueckler-Str. 44, 50935 Cologne, Germany
5
Clinic for Gastroenterology, Metabolic Disorders and Internal Intensive Medicine (Medical Clinic III), RWTH Aachen, Pauwelsstr. 44, 52074 Aachen, Germany
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Nutrients 2022, 14(1), 77; https://doi.org/10.3390/nu14010077
Submission received: 24 November 2021 / Revised: 19 December 2021 / Accepted: 20 December 2021 / Published: 24 December 2021
(This article belongs to the Section Nutritional Epidemiology)
Browse Figure
Versions Notes

Abstract

:
Chronic psychological stress can result in physiological and mental health risks via the activation of the hypothalamic–pituitary–adrenal (HPA) axis, sympathoadrenal activity and emotion-focused coping strategies. The impact of different stress loads on cardiometabolic risk is poorly understood. This post hoc analysis of a randomized pilot study was conducted on 61 participants (18–65 years of age) with perceived chronic stress. The Perceived Stress Questionnaire (PSQ30), Psychological Neurological Questionnaire (PNF), anthropometric, clinical and blood parameters were assessed. Subjects were assigned to ‘high stress’ (HS; PSQ30 score: 0.573 ± 0.057) and ‘very high stress’ (VHS; PSQ30 score: 0.771 ± 0.069) groups based on the PSQ30. Morning salivary cortisol and CRP were elevated in both groups. Visceral adiposity, elevated blood pressure and metabolic syndrome were significantly more frequent in the HS group vs. the VHS group. The fatty liver index (FLI) was higher (p = 0.045), while the PNF score was lower (p < 0.001) in the HS group. The HS group was comprised of more smokers (p = 0.016). Energy intake and physical activity levels were similar in both groups. Thus, high chronic stress was related to visceral adiposity, FLI, elevated blood pressure and metabolic syndrome in the HS group, while very high chronic stress was associated with psychological–neurological symptoms and a lower cardiometabolic risk in the VHS group, probably due to different coping strategies.

1. Introduction

Chronic psychological stress is increasingly recognized as a significant contributor to mental and physiological disorders in modern societies [1,2,3]. The term ‘stress’ is used to describe physiological and behavioral responses to real or perceived intrinsic or extrinsic stimuli or ‘stressors’ threatening homeostasis [4,5]. The brain is the central organ of the perception and the response to stress. It operates as part of a complex and non-linear network via the sympathetic and parasympathetic systems, the hypothalamic–pituitary–adrenal (HPA) axis, the immune system, metabolic hormones and molecular processes within all organs to promote adaptation (‘allostasis’) to protect the body. However, exposure to perceived chronic stress leads to an overuse of these mediators, and adaptation to the chronicity can result in persistent dysregulation that contributes to stress-related pathophysiology (‘allostatic load’) [6,7,8,9,10].
The individual response to chronic stressors and resulting disorders depends on numerous factors such as genetic predisposition, stress intensity, stress susceptibility, neural processing, and subsequent compensatory adjustments, social environment, coping strategies, as well as the chronicity of exposure [10,11,12,13]. Yet, there is little agreement about what aspects and dimensions of the complex construct ‘stress’ matter most for human health and disease [14]. Major life stressors involving interpersonal stress, social rejection, combinations of high mental demands and low decision latitude as well as high efforts and low rewards are considered to be among the strongest prospective psychosocial risk factors for mental disorders [15,16]. In Germany, sleep disturbances, diagnosed burnout syndrome, and depressive symptoms were much more frequent in people with a high chronic stress level than in those without high levels of stress [17]. Likewise, in a working age population in Sweden [18] and in female undergraduates in the United States of America [19], a higher level of perceived chronic stress was often accompanied by symptoms of depression and/or anxiety. In comparison with these results, Sara et al. [20] showed that individuals with chronic job strain, effort–reward imbalance, or organizational injustice are at an increased risk of cardiovascular diseases (CVD), directly or through mediating factors such as hypertension, high cholesterol, or maladaptive behaviors. Moreover, long working hours were found to be related to an excess risk of shift from a normal weight to being overweight [21]. A meta-analysis of Tenk et al. [22] showed a significant association between perceived stress and visceral adiposity as well as lipid parameters of the metabolic syndrome. However, in female nurses, no association was found between burnout and metabolic syndrome, but night shifts, emotional exhaustion and personal accomplishment were related to an increased waist circumference [23]. Long-term spousal caregiving was associated with double the risk of CVD onset [24]. However, the psychological and physiological health impact of caregiving as chronic stress exposure is highly variable, driven largely by the intensity of care provided and the suffering of the care recipient [25,26].
The ‘selfish brain’ theory of Peters et al. [27] was an advance in understanding the central role of the neocortex and limbic system in the pathogenesis of metabolic abnormalities by the expansion of the allostatic load model upon the energetic demands of the brain [28]. Under stressful conditions, the brain behaves in a ‘selfish’ manner and demands extra energy. It actively regulates its own energy supply from the body by using a brain-pull mechanism to satisfy its increased energetic needs prior to other organs. This leads to a ‘cerebral insulin suppression’ to limit glucose fluxes into peripheral tissue, and to enhance cerebral glucose supply. Furthermore, the brain changes eating behaviors in the post-stress phase according to its needs [29,30,31]. People who develop divergent patterns of fat distribution during psychological stress over the course of their life were found. People with high psychological distress combined with low autonomic variability who habituate will be able to tolerate aversive circumstances by buffering the allostatic load, were prone to developing subcutaneous fat accumulation (the corpulent phenotype). However, they did not accumulate much visceral fat, and their cardiovascular mortality risk remains low [28,32]. People who experience the unbuffered allostatic overload of chronic stress belong to the non-habituators that display compromised recovery during a persistent cerebral energy crisis. These neuroenergetic alterations promote visceral fat accumulation (the wide-waisted phenotype), subcutaneous fat loss, and atherogenesis with subsequent cardiovascular events [28,31]. The non-habituators viewed themselves as having less self-esteem, and being more often in a depressed mood than the habituators [33]. Their life-long risk for mental and physical disorders is increased [34]. Therefore, chronic stress without habituation seems to be a key player in the vicious cycle to cardiometabolic disturbances such as visceral adiposity, hyperglycemia, dyslipidemia, and hypertension, collectively named as ‘metabolic syndrome’ with a high risk for CVD [35,36,37,38,39,40,41]. Non-alcoholic fatty liver disease (NAFLD) is strongly related to these cardiometabolic risk factors, but there is also a direct link to chronic psychological stress via increased levels of pro-inflammatory cytokines, cortisol and epinephrine [42,43].
A characteristic body fat distribution plays a key role in the concept of metabolically healthy and unhealthy obese (MHO vs. MUHO) phenotypes. Stefan et al. [44] and Wildman et al. [45] recognized subgroups of individuals with obesity and overweight as having a significantly lower risk of cardiometabolic abnormalities, while a subgroup among normal-weight individuals was surprisingly found to be metabolically unhealthy. Lower amounts of ectopic fat, particularly in the liver and visceral, were observed in the metabolically healthy phenotypes. Moreover, an impaired ability to expand subcutaneous fat resulted in metabolically unhealthy phenotypes [46,47].
Individuals have multidimensional ways to cope with stress. There are aspects of problem-focused and emotion-focused coping strategies [48,49]. Problem-focused stress management strategies attempt to alter the relationship with the environment, whereas emotion-focused stress management strategies aim at reducing, tolerating, or eliminating stress sensations. Negative emotion-focused coping strategies involve the avoidance of stress-related feelings, and preferences for energy-dense foods and overeating, smoking, shorter sleep and a sedentary lifestyle are associated with worse health outcomes later [50]. However, physical activity has the effect of selecting efficient and appropriate coping strategies and reducing the intensity of the stress response [51]. A growing number of studies examined the relationship between psychological stress and cardiometabolic or mental health risk [20]. In the current understanding, there is a missing link, whether high and very high perceived chronic stress loads have a different impact on cardiometabolic dysfunctions highlighting novel therapeutic targets to combat CVD at a population level. Thus, the aim of this study was to investigate the cardiometabolic risk profile in participants with ‘high’ and ‘very high’ chronic stress loads and the impact of positive and negative coping factors used.

2. Materials and Methods

2.1. Questionnaires: The Perceived Stress Questionnaire (PSQ30) and the Psychological Neurological Questionnaire (PNF)

Perceived chronic psychological stress was defined by an elevated level of the German version of the standardized PSQ30 [52]. The PSQ30 assesses the extent of a subjectively perceived stress in the context of a transactional view of stress [53]. This valid instrument includes 30 items that are applicable to adults of any stage of life, sex, or occupation, but interpretable as specific to a variety of real-life situations. The items are assigned to the seven scales harassment, overload, irritability, lack of joy, fatigue, worries, and tension. The items are worded in such a way that the neutral, cognitive aspect of experience is emphasized and were answered with a four-point rating scale (1 = almost never, 2 = sometimes, 3 = often, and 4 = usually). Mean values for the seven scales were calculated. The total PSQ30 score was derived from the raw item scores that were linearly transformed to values between zero (lowest possible level of stress) and one (highest possible level of stress) [53].
The subjective psychological–neurological symptoms of the participants were assessed by the PNF, a questionnaire originally used by occupational medicine [52,54]. It comprises a total of 38 items about the frequency of psychological–neurological symptoms within the past three months. These items are divided into five categories of neurovegetative disturbances: psychoneurovegetative stability, neurological symptoms, impulsion, excitability, concentration, and memory [52,54]. The self-reported symptoms were assessed as total points, including for individual categories ranging from ‘not at all’ (0 points) to ‘often’ (3 points).

2.2. Participants

Women and men aged 18 to 65 years with subjectively perceived chronic stress and exhaustion conditions, such as symptoms of burnout, were recruited via local media and online advertising, internal mail systems, flyers and printed media in the Cologne/Bonn region, Germany. At the beginning of the study, all participants had to indicate being progressively exhausted based on the chronic stress experience. Participants with a total PSQ30 score above 0.50 were included in the study. Similar to Kocalevent et al. [53], the median of the total PSQ30 scores determines the division of the ‘high stress group (HS group)’ and the ‘very high stress group (VHS group)’ in the ITT population.
The exclusion criteria for participation were therapy with antidepressants, hypertension (untreated > 150/90 mmHg, treated > 140/85 mmHg), supplementation or therapy with dietary supplements or drugs that contained L-tryptophan, vitamins, or minerals within four weeks prior to and for the duration of the study, organic fatigue, phenylketonuria, and chronic diarrhea. Informed consent was obtained from each participant prior to the start of the study. The study was approved by the Freiburg International Ethics Commission. This study was retrospectively registered (NCT02997137).

2.3. Study Design

This post hoc analysis was performed with the baseline data of the BOT-01 study, a randomized, double-blind, placebo-controlled intervention trial on the impact of a specific amino acid composition with micronutrients on well-being in subjects with chronic psychological stress and exhaustion conditions [52]. The enrolment and baseline examinations were performed at the University Hospital Bonn between October 2014 and January 2016. At baseline, participants underwent an assessment, including detailed anamnesis with questions on individual factors, social environmental factors and problem-focused and/or emotion-focused coping factors. Moreover, the PSQ30, the PNF, anthropometric and clinical measurements, blood parameters, salivary samples and dietary intake were assessed. Seven days before baseline, all participants received detailed instructions in written and oral form for taking saliva cortisol samples and accurate recording of dietary intakes. At baseline, after a seven-day pre-randomization run-in period, participants were assigned to one of two intervention groups via computer-generated randomization with a block size of four [52].

2.4. Anthropometric and Clinical Measurements

Anthropometric and clinical measurements were performed in the morning after an overnight fasting period of at least 12 h and under standardized conditions. Body weight and height were determined on a personal floor scale with a height measuring stick (MPE-HM, KERN, Balingen, Germany). Body mass index (BMI, kg/m2) was calculated. Waist circumference (WC) was measured via flexible tape [52]. After a 10 min resting period in a seated position, three successive measurements of blood pressure (BP) and heart rate were obtained using a digital automatic upper arm BP monitor (model M10-IT, Omron Healthcare Europe B.V., Hoofddorp, The Netherlands) [52]. These accumulated clinical measurements were averaged to determine systolic and diastolic BP and resting heart rate.

2.5. Biochemical Analysis

The Laboratory Schottdorf MVZ GmbH (Augsburg, Germany) conducted the laboratory analyses (for further details, see [52]). Saliva samples were collected in the evening (between 10 and 11 p.m.) and in the morning (30 min after awakening) at baseline. The collections were performed according to the laboratory instructions. Participants were instructed not to eat, drink, or smoke for at least 30 min prior to evening saliva collection. Saliva collection in the morning followed an overnight fasting period of at least 12 h. Participants were not allowed to have brushed their teeth before both saliva samples were taken. Therefore, sterile cotton swabs, Cortisol–Salivette® (Sarstedt, Nümbrecht, Germany), were chewed during 30 to 60 s, deposited in collection tubes and subsequently stored in a refrigerator. Salivary cortisol concentrations were determined using Cortisol ELISA (IBL, Hamburg, Germany) and the microplate reader SUNRISE (Tecan, Crailsheim, Germany).
At baseline, venous blood samples were obtained after an overnight fasting period of at least 12 h. The participants received detailed instructions in oral and written form to avoid serotonin- and/or tryptophan-rich foods 2–3 days before blood sampling due to the determination of serum serotonin. Serum glucose (hexokinase method), glycated hemoglobin (HbA1c; turbidimetric immunologic inhibition assay), insulin (ECLIA), gamma-glutamyltransferase (GGT; IFCC method), total cholesterol (TC; CHOD-PAP method), low-density lipoprotein-cholesterol (LDL-C) and high-density lipoprotein-cholesterol (HDL-C; enzymatic color test), triglycerides (TG; GPO-PAP method), and sensitive C-reactive protein (CRP; turbidimetry) were measured using a Roche analyzer. The diagnosis of metabolic syndrome, including individual components such as blood pressure, was made according to the NCEP criteria [41]. Insulin and glucose values were used to calculate the homeostasis model assessment (HOMA) index, which is a measure of insulin resistance. Serum amino acids and serotonin were determined.
The self-reported dietary intake data (three-day food records) were reviewed with each participant. PRODI 6.4 basis software (WVG, Stuttgart, Germany) with database BLS 3.02 was used to calculate the nutrient content of foods. The average of three days was assessed.

2.6. Statistical Analysis

Statistical analysis was performed by using SPSS® for Windows (version 24.0, IBM, Armonk, NY, USA). An explorative post hoc analysis was conducted. Data are presented as mean ± standard deviation (SD). Statistical comparisons were performed using the nonparametric Mann–Whitney U test. The exact tests were used due to the small sample size. Differences in classified variables were tested via Fisher’s exact test. The relationship between different parameters and their effects on the metabolism were modelled via parametric linear regression analysis, including age as a covariate. All statistical tests were two-sided. A p value of < 0.05 was considered statistically significant.

3. Results

3.1. Participants

For this analysis, baseline data were available for 62 chronic psychologically stressed participants, of whom 61 participants (43 women and 18 men) were included in the intention-to-treat (ITT) population. One participant had to be excluded from the study due to abnormal blood values such as liver transaminases and CRP. Table 1 shows the characteristics of the participants.
The median of 0.656 of the total PSQ30 results of participants determined the assignment to the HS group (total PSQ30 score of 0.500–0.656) and the VHS group (total PSQ30 score > 0.656). Thus, this group classification caused the significant group difference in the total PSQ30 score. The mean total PSQ30 score of the VHS group was 1.35 times higher compared to the HS group. In the HS group, there were four times more smokers and significantly less perceived neurovegetative symptoms than in the VHS group. There were no significant group differences in marital status and the number of children. The number of participants who cared for a family member in need or work in shifts was similar in both groups. In the HS group, 32.3% of the participants did no regular physical activity compared to only 13.3% in the VHS group, but without significant group differences.

3.2. Anthropometric, Clinical, and Biochemical Parameters

Among all participants, 18.0% were obese, 45.9% had visceral adiposity, 18.0% had elevated blood pressure, and a fatty liver index (FLI) of ≥60 was found in 23.0% (Table 2). In the HS group, visceral adiposity, high blood pressure and metabolic syndrome were more frequent than in the VHS group. Moreover, a significantly higher FLI, LDL-C/HDL-C, and TC/HDL-C quotient were detected in the HS group compared to the VHS group.
In both groups, there was an elevated mean salivary cortisol level in the morning (Table 2). No significant group differences in salivary cortisol, serotonin concentrations (Table 2), serum amino acid concentrations (Table S1), or in dietary energy and nutrients intake (Table S2) were observed. In the ITT population, significant negative correlations were found between the total PSQ30 score and the FLI, LDL-C/HDL-C quotient and insulin concentration (Figure 1). These correlations were characterized by high but not very high perceived stress values in combination with data above the laboratory cut-off values. Thus, participants with a high chronic stress load were at higher cardiometabolic risk than participants with a very high chronic stress load (Figure 1). After age adjusting, similar results were observed via linear regression between the total PSQ30 score and the FLI (RCB: −63.951, p = 0.032; p value for age = 0.017), LDL-C/HDL-C quotient (RCB: −2.413, p = 0.019; p value for age = 0.040) and insulin concentration (RCB: −11.824, p = 0.010; p value for age = 0.782).

3.3. Inflammation, Indirect Markers of Oxidative Stress, Antioxidative Parameters and the Cardiometabolic Risk Profile

No significant difference between the HS group and the VHS group was found in the indirect markers of oxidative stress and inflammation, i.e., ferritin, GGT, CRP, uric acid, folic acid and HbA1c (Table 2). An elevated CRP concentration was observed in both groups (Table 2). Among all participants, CRP, uric acid concentrations, FLI (Table 3), and GGT (Table S3) correlated significantly positive with weight, WC, insulin, and TG concentrations, as well as significantly negative with the HDL-C concentration, while the HbA1c concentration correlated significantly with the FLI (Table 3), but not with CRP (Table 3), GGT (Table S3), and uric acid concentrations (Table 3).
Within both groups, the FLI correlated significantly positive with WC, and TG, as well as significantly negative with the HDL-C concentration (Table 3). However, similar significant correlations of the CRP concentration with WC, TG and HDL-C concentrations were observed only in the HS group (Table 3). Additionally, within the HS group, the FLI correlated significantly with insulin, FPG, and HbA1c concentrations, as well as with the HOMA index, while significant correlations were detected between the FLI and the BP as well as the uric acid concentration only in the VHS group (Table 3). Moreover, CRP concentration correlated significantly with insulin concentration, HOMA index and heart rate only in the VHS group, while uric acid concentration correlated significantly positive with insulin concentration only in the HS group, and positive with HbA1c and negative with HDL-C concentration only in the VHS group (Table 3).
In the ITT population, no significant effect was detected between the nutritional antioxidant intake and the indirect oxidative stress and inflammation markers, except for a positive correlation between the vitamin B12 intake and the ferritin concentration (Table S3). However, in the VHS group, a significant correlation between folic acid concentration and FLI was detected (Table 3). No significant association between the total PSQ30 score and markers of oxidative stress and inflammation were found (Table S3), except for a negative correlation between the total PSQ30 score and the FLI in the ITT population (p = 0.032) (Table 3).

3.4. Coping Strategies and Cardiometabolic Risk

The comparison between the chronic perceived stress load and the cardiometabolic risk depending on the coping strategies ‘allostatic load’ resulting in visceral adiposity, ‘smoking’, and ‘regular physical activity’ is shown in the ITT population and for both stress groups (Table 4). In the ITT population, participants with visceral adiposity had a higher FLI (p < 0.001), a higher HOMA index (p = 0.002), and a higher CRP concentration (p = 0.024) but a perceived lower chronic stress (p = 0.003) than participants without increased visceral fat accumulation (Table 4).
The FLI was higher in participants with visceral adiposity in the HS group (p < 0.001) and in the VHS group (p = 0.005). No significant group difference in perceived chronic stress was found between participants with and without visceral adiposity within the HS group (p = 0.992) and the VHS group (p = 0.072) (Table 4). Moreover, participants with visceral adiposity had a significantly higher CRP concentration (p = 0.012) and a higher HOMA index (p < 0.001) only in the HS group, while a higher HbA1c (p = 0.034) was found only in the VHS group (Table 4).
Among all participants, smokers perceived less frequent chronic stress than non-smokers (p = 0.008), without a significant group difference in the CRP concentration (p = 0.091, Table 4). However, in the VHS group, smokers had a lower HbA1c (p = 0.024) and a lower uric acid concentration (p = 0.031) than non-smokers (Table 4).
Participants with regular physical activity had a higher HDL-C concentration (p = 0.006) and a lower resting heart rate (p = 0.008) but perceived more frequent chronic stress (p = 0.039) than inactive participants in the ITT population (Table 4). Within both groups, active and inactive participants had a similar chronic stress level, while active participants showed a more favorable HDL-C concentration and resting heart rate only in the HS group (Table 4).

4. Discussion

The present study shows that the stress load can be coped with in different ways and that the coping strategy is crucial for cardiometabolic risk. The data indicate that perceiving high chronic stress is significantly associated with the criteria of the metabolic syndrome according to NCEP in the HS group. In contrast, subjects in the VHS group with very high chronic stress perceived psychological–neurological symptoms and neurovegetative disturbances significantly more frequently. As a consequence, at the time of data evaluation, individuals with very high chronic stress had a lower risk of cardiometabolic disturbance. It is postulated that participants with very high chronic stress are more prone to mental illnesses compared to participants with a high chronic stress load. Differences in stress habituation and coping strategies used seemed to be of great importance for the various health risks in these study groups. It is emphasized that very high chronic stress did not decrease the cardiometabolic risk.
Chronic stressors act in a complex way on a person’s mood, behavior, physiological and mental health [6,55]. In the HS group, there were significantly more subjects with visceral adiposity, high liver fat, metabolic syndrome, and elevated blood pressure compared to the VHS group. Thus, different perceived chronic stress loads seemed to have a different impact on visceral fat accumulation and blood pressure, leading to a clearly increased cardiometabolic risk in subjects with high perceived chronic stress. Previous studies showed that perceived stress might have an influence on blood pressure, while no association was found regarding distress [56]. An association between less perceived stress and higher blood pressure levels was noted in several studies [57,58]. Björntorp [59], who provided a basis for understanding how stress mediators damage the cardiovascular system, how habituation protects the vasculature, and why the different fat distribution patterns display diverging prognostic values was used by Peters et al. [28,29,60] in the ‘selfish brain’ theory. In the ‘non-habituators’, psychosocial stress leads to a release of neuropeptide Y (NPY) from sympathetic nerves. NPY and its receptors get up regulated in a glucocorticoid-dependent manner in the visceral fat. This NPY response results in an increase in visceral fat mass in order to supply the brain with extra fuel from an extra-cerebrally located energy depot [28,31,61]. Therefore, chronic stress-induced peripheral NPY plays a mechanistic role in the enhanced vulnerability to visceral obesity, insulin resistance and oxidative stress [36,62]. In the present study, the HS group seemed to be comparable to these ‘non-habituators’ and their phenotypic change as a long-term adaptation to chronic stress via visceral fat accumulation. The ‘habituators’ are characterized as tolerating aversive circumstances by buffering the allostatic load without developing large visceral fat depots. However, they can predominantly accumulate subcutaneous fat under chronic stress, which is their trade-off [28,35,63]. There were fewer participants with visceral adiposity in the present VHS group; conversely, ‘habituators’ were described as experiencing tolerable stress, while ‘non-habituators’ experience toxic stress. However, participants of the VHS group perceived higher chronic stress and a lower cardiometabolic risk than the HS group but suffered neurovegetative disturbances more often. As a consequence, the VHS group cannot be classified as ‘habituators’. Mixed or new phenotypes with cardiometabolic and mental health risk within high chronic stress loads are presumed. In the present HS group, this adaptation to chronic stress seemed to be a negative passive coping strategy to habituate to the high stress load as an initial evolutionary advance in resource management but was hazardous to the cardiometabolic health consequences. In the VHS group, the participants seemed to be more or less protected against such cardiometabolic complications for the moment, but a non-habituation to the toxic stress load with a risk for mental health is presumed. Thus, the present results of the different stress groups can be divided into metabolically healthy and metabolically unhealthy high chronic stress phenotypes following the concept of Stefan et al. [44,64]. These participants seem to have a different susceptibility to visceral adiposity to adapt to the chronic stress load. Due to the fact that both groups had a similar BMI, in the HS group, a loss of subcutaneous fat via SMS-activation and release of free fatty acids into the venous system as well as an increased visceral fat mass by the alteration of the HPA-axis resulting in a shift in body composition is supposed [65,66]. The VHS group seemed to be protected against increased visceral fat accumulation by non-adaptation to the chronic stress load. However, the chronic stress response may lead to a neurobiological ‘slippery slope’ from chronic stress to mental illness, and further, to cardiometabolic diseases [67]. Thus, long-term studies of metabolically healthy vs. metabolically unhealthy individuals with a chronic stress load would provide a timely opportunity for the prevention or earlier specific intervention of stress-related cardiometabolic or mental health risk.
Chronic stress can lead to chronically elevated glucocorticoids that increase the salience of pleasurable or compulsive activities, such as eating high energy ‘comfort food’ via its interaction with the central reward pathways. This circuitry can suppress the HPA axis activation and the feeling of stress [68,69]. A chronically high concentration of glucocorticoids acts systemically with peripheral Neuropeptide Y (NPY), which has anxiolytic activities and acts as the most powerful hunger stimulator in the body to increase abdominal fat depots. These abdominal energy stores send an increased signal to inhibit catecholamines in the brainstem and hypothalamic neurons [68]. Dichotomous effects of chronic stress on metabolic outcomes were found, partly due to the inherent complexity exemplified by the bidirectional effect of stress on eating behaviors and body weight [66]. In total, 25.8% of the participants in the present HS group and 10.0% of the participants in the VHS group are obese, but without group differences. Visceral adiposity was significantly more frequent in the HS group vs. the VHS group. Thus, the prevalence of obesity in the HS group is higher, than in the general German population, with 18.9% of obese men and 22.5% of obese women [70]. No significant difference in the BMI, energy intake, as well as intake of macro- and micronutrients was found between the HS and VHS groups. Thus, the supposed effects of different stress loads on the nutrient intake and emotional eating as a coping strategy were not detected. However, in healthy men with lower chronic stress exposure, a stronger acylated ghrelin response after acute stress exposure compared with a control condition was found, while healthy men with higher chronic stress exposure showed a blunted acylated ghrelin response after acute stress exposure. Consequently, a subsequent food intake is affected differently [71]. Richardson et al. [72] found a positive association between perceived stress and emotional eating but higher stress was not associated with weight status through eating behaviors and diet quality. Geschwind et al. [73] showed that the experience of high daily life rewards can preserve mental health.
In Germany, depressive symptoms, burnout syndrome, and sleep disturbances are more common in people with high levels of chronic stress than without high levels of stress [17]. In the present study, both chronic stress groups suffered from increased psychological neurological symptoms. Participants in the VHS group perceived these neurovegetative disturbances to a higher degree than the HS group. The negative coping strategy smoking was more often evaluated in participants in the HS group than in the VHS group to reduce perceived stress. Smokers were related to lower chronic stress perception than non-smokers. This result confirmed the regulatory role of nicotine in the regulation of stress mediated by the hypothalamus and the reward pathways [74,75] with an increased cardiometabolic health risk [76]. Smoking, the greatest exogenous oxidative stressor [77], is reflected in the increased cardiometabolic risk of the HS group. Moreover, both stress groups used regular physical activity as a positive coping strategy [78,79] to a similar extent. However, participants with regular physical activity perceived a higher stress load than participants without regular physical activity. In general, the experience of stress impairs efforts to be physically active, especially in chronically stressed populations. Nonetheless, stress can positively be impacted by physical activity via behavioral activation through individuals utilizing exercise to cope with stress [80,81].
Thus, participants in the present study, who used physical activity as a coping strategy, had a higher total PSQ30 score compared to physically inactive participants with a lower total PSQ30 score, who had a higher risk for more frequent negative coping strategies, such as smoking or visceral fat accumulation. The extent of the physical activity level and stress reduction since these participants started with regular physical activity are unknown. An increased risk in gradually replacing regular physical activity by a less time-consuming, negative coping strategy is supposed in individuals with chronic stress. Physical activity is associated with better cardiometabolic outcomes [79,82]. In the present study, regular physical activity was associated with lower resting heart rate and higher HDL-C concentration. Exercise, especially endurance training and yoga, can decrease resting heart rate [83]. A higher resting heart rate is independently associated with an increased risk of cardiovascular mortality [84]. Furthermore, physical activity can improve the antioxidative and anti-inflammatory properties of HDL-C concentration [85].
Chronic stress can lead to low grade inflammation, causing fat accumulation in the liver cells. A persistent inflammation of the liver can result in liver damage. Non-alcoholic fatty liver disease (NAFLD) is a stress-sensitive disorder [86]. A cross-sectional study observed a positive association between perceived stress and NAFLD in apparently healthy women and men [87]. These results indicate that elevated cardiometabolic risk is clearly assigned to participants with a high compared to a very high chronic stress load due to stress coping by visceral fat accumulation. Madhu et al. [88] demonstrated that high chronic stress is associated with a high risk of diabetes mellitus. Subjects with very high chronic stress without visceral adiposity as a stress coping strategy seemed to be protected from this cardiometabolic risk. A relative balance of adaptive and maladaptive coping strategies used is associated with better coping outcomes in the context of chronic illness [89]. However, the healthy brain has a considerable capacity for resilience based upon its ability to respond. Treatments should be given or used by positive behavioral interventions; negative experiences may even make matters worse [90].
In the present study, markers of inflammation and oxidative stress, such as CRP sensitive, GGT, and uric acid were associated with numerous cardiometabolic risk parameters. Both stress groups had increased CRP concentrations. Chronic stressors, such as family dementia caregiving or job strain, promote a state of chronic low-grade elevation in circulating inflammatory markers [91]. Elevations in systemic CRP levels are related to greater incidence of depression, cardiovascular disorders and diabetes, providing a physiological pathway for chronic stress to possibly harm health [92,93,94]. Chronic psychological stress should be considered when interpreting the meaning of CRP elevations [95]. The role of uric acid in cardiometabolic disease is controversial. Hyperuricemia is associated with an increased risk of metabolic syndrome, hypertension, coronary heart disease, insulin resistance, and NAFLD [96,97,98]. Conversely, uric acid plays a protective role in oxidative stress by acting as an active oxygen scavenger with an antioxidant effect, and can prevent cardiovascular diseases (CVD) [97,99]. In the VHS group, uric acid was positively associated with systolic and diastolic blood pressure as well as folic acid concentration. The folic acid concentration was related to FLI in the VHS group. These relationships were not detected in the HS group. Folic acid has a significant inhibition property in microsomal lipid peroxidation, a free radical scavenging behavior [100]. One suggested explanation for the reduced cardiometabolic risk of the VHS group compared to the HS group is a still functioning protective antioxidant capacity, also due to the lower number of smokers in the VHS group. Over time, this condition will possibly change to an adaptation to the HPA-axis dysregulation with increased cardiometabolic risk.
In the VHS group, eight out of thirty subjects had visceral obesity. In the eight participants, visceral adiposity was associated with higher HbA1c and FLI. Moreover, common risk factors of NAFLD [101,102], such as BMI, WC, BP, TG and HDL-C, were related to FLI in the VHS group. A gradual shift of these participants from a very high chronic stress load to a high chronic stress load with higher cardiometabolic risk is presumed. In the HS group, the 20 participants with visceral adiposity had a significant higher FLI, HOMA index, and CRP compared to participants without visceral adiposity. These are already well-known cardiometabolic risk factors associated with visceral adiposity [101]. Moreover, there were significant inverse correlations between the perceived chronic stress and the fatty liver index, LDL-C/HDL-C quotient, and insulin concentration among all participants. As expected, the FLI was associated with WC and insulin, TG, and HDL-C concentrations. All these parameters are related to the metabolic syndrome and increased cardiovascular mortality risk [103]. The meta-analysis of Kuo et al. [104] showed that adults with high stress have an increased risk of having metabolic syndrome than adults with low stress.
The small number of cases and the short study period are limiting factors. Further studies with larger cohorts should investigate different high chronic stress groups, their habituation to stress, and the consequences of cardiometabolic and mental health risks in a long-term study. Further limitations are the lack of a control group, the wide age range of the participants (18 to 65 years of age) and the impossibility of an analysis of sex differences due to the small number of participants.

5. Conclusions

These findings indicate that high perceived chronic stress is related to visceral obesity, elevated blood pressure, metabolic syndrome and high liver fat, with a high cardiometabolic risk due to stress-induced disturbances of the HPA axis and maladaptive coping strategies used. On the contrary, a very high perceived chronic stress load seemed to be rather associated with mental health risk than with cardiometabolic risk. Participants in the HS group habituated to their stress load by using coping strategies, such as smoking, and an ‘allostatic load’ that resulted in visceral adiposity in dealing with the perceived chronic stress but was hazardous to the cardiometabolic health consequences. Participants in the VHS group are not currently capable of habituating to their perceived chronic stress but seemed to be cardiometabolically healthier. As expected, inflammation and oxidative stress markers significantly correlated with cardiometabolic risk parameters. Participants using the coping strategy ‘regular physical activity’ had a significantly higher HDL-C concentration and a lower resting heart rate than inactive participants. However, long-term studies are necessary to examine further adaptations to chronic stress in both groups and to evaluate individual stress-management strategies.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/nu14010077/s1, Table S1: Serum amino acid concentrations of participants, Table S2: Dietary intake of participants, Table S3: Relationship of cardiometabolic risk parameters and GGT as well as ferritin concentrations in the ITT population (age-adjusted).

Author Contributions

C.M. was the scientific project manager and designed the study; D.A. conducted the study and analyzed the data; R.S. coordinated the study; N.B. was responsible for the statistical analysis; D.R. carried out the monitoring; D.A. wrote the article, which was reviewed and edited by R.S.; C.M., R.S., N.B., B.A. and D.R. critically revised the article. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Kyberg Vital GmbH, Oberhaching, Germany.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the Freiburg International Ethics Commission (protocol code: 014/588 and date of approval: 15 September 2014).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request.

Acknowledgments

We would like to express our gratitude to those who participated in the study.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. World Health Assembly. Follow-Up to the Political Declaration of the High-Level Meeting of the General Assembly on the Prevention and Control of Non-Communicable Diseases. 2013. Available online: https://apps.who.int/iris/handle/10665/150161 (accessed on 14 September 2021).
  2. Cohen, B.E.; Edmondson, D.; Kronish, I.M. State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease. Am. J. Hypertens. 2015, 28, 1295–1302. [Google Scholar] [CrossRef] [Green Version]
  3. Wirtz, P.H.; von Känel, R. Psychological Stress, Inflammation, and Coronary Heart Disease. Curr. Cardiol. Rep. 2017, 19, 111. [Google Scholar] [CrossRef]
  4. Yaribeygi, H.; Panahi, Y.; Sahraei, H.; Johnston, T.P.; Sahebkar, A. The impact of stress on body function: A review. EXCLI J. 2017, 16, 1057–1072. [Google Scholar] [CrossRef] [PubMed]
  5. Goldstein, D.S.; McEwen, B. Allostasis, homeostats, and the nature of stress. Stress 2002, 5, 55–58. [Google Scholar] [CrossRef]
  6. McEwen, B.S. Neurobiological and Systemic Effects of Chronic Stress. Chronic Stress 2017, 1, 1–11. [Google Scholar] [CrossRef] [Green Version]
  7. McEwen, B.S.; Eiland, L.; Hunter, R.G.; Miller, M.M. Stress and anxiety: Structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 2012, 62, 3–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Coffman, J.A. Chronic stress, physiological adaptation and developmental programming of the neuroendocrine stress system. Future Neurol. 2020, 15, FNL39. [Google Scholar] [CrossRef]
  9. McEwen, B.S. The brain is the central organ of stress and adaptation. NeuroImage 2009, 47, 911–913. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Juster, R.-P.; McEwen, B.S.; Lupien, S.J. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci. Biobehav. Rev. 2010, 35, 2–16. [Google Scholar] [CrossRef] [PubMed]
  11. Goldstein, D.S. Stress, allostatic load, catecholamines, and other neurotransmitters in neurodegenerative diseases. Cell. Mol. Neurobiol. 2012, 32, 661–666. [Google Scholar] [CrossRef] [Green Version]
  12. Ebner, K.; Singewald, N. Individual differences in stress susceptibility and stress inhibitory mechanisms. Curr. Opin. Behav. Sci. 2017, 14, 54–64. [Google Scholar] [CrossRef]
  13. Wüst, S.; Federenko, I.; Hellhammer, D.H.; Kirschbaum, C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000, 25, 707–720. [Google Scholar] [CrossRef]
  14. Epel, E.S.; Crosswell, A.D.; Mayer, S.E.; Prather, A.A.; Slavich, G.M.; Puterman, E.; Mendes, W.B. More than a feeling: A unified view of stress measurement for population science. Front. Neuroendocrinol. 2018, 49, 146–169. [Google Scholar] [CrossRef] [PubMed]
  15. Slavich, G.M.; Irwin, M.R. From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychol. Bull. 2014, 140, 774–815. [Google Scholar] [CrossRef] [PubMed]
  16. Stransfeld, S.; Bridget, C. Psychosocial work environment and mental health—A meta-analytic review. Scand. J. Environ. Health 2006, 32, 443–462. [Google Scholar] [CrossRef]
  17. Hapke, U.; Maske, U.E.; Scheidt-Nave, C.; Bode, L.; Schlack, R.; Busch, M.A. Chronic stress among adults in Germany. Results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt 2013, 56, 749–754. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Wiegner, L.; Hange, D.; Björkelund, C.; Ahlborg, G. Prevalence of perceived stress and associations to symptoms of exhaustion, depression and anxiety in a working age population seeking primary care--an observational study. BMC Fam. Prac. 2015, 16, 38. [Google Scholar] [CrossRef] [PubMed]
  19. Klatzkin, R.R.; Baldassaro, A.; Hayden, E. The impact of chronic stress on the predictors of acute stress-induced eating in women. Appetite 2018, 123, 343–351. [Google Scholar] [CrossRef] [PubMed]
  20. Sara, J.D.; Prasad, M.; Eleid, M.F.; Zhang, M.; Widmer, R.J.; Lerman, A. Association Between Work-Related Stress and Coronary Heart Disease: A Review of Prospective Studies Through the Job Strain, Effort-Reward Balance, and Organizational Justice Models. J. Am. Heart Assoc. 2018, 7, e008073. [Google Scholar] [CrossRef] [Green Version]
  21. Virtanen, M.; Jokela, M.; Lallukka, T.; Hanson, L.M.; Pentti, J.; Nyberg, S.T.; Alfredsson, L.; Batty, G.D.; Casini, A.; Clays, E.; et al. Long working hours and change in body weight: Analysis of individual-participant data from 19 cohort studies. Int. J. Obes. 2020, 44, 1368–1375. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Tenk, J.; Mátrai, P.; Hegyi, P.; Rostás, I.; Garami, A.; Szabó, I.; Hartmann, P.; Pétervári, E.; Czopf, L.; Hussain, A.; et al. Perceived stress correlates with visceral obesity and lipid parameters of the metabolic syndrome: A systematic review and meta-analysis. Psychoneuroendocrinology 2018, 95, 63–73. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Chico-Barba, G.; Jiménez-Limas, K.; Sánchez-Jiménez, B.; Sámano, R.; Rodríguez-Ventura, A.L.; Castillo-Pérez, R.; Tolentino, M. Burnout and Metabolic Syndrome in Female Nurses: An Observational Study. Int. J. Environ. Res. Public Health 2019, 16, 1993. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Capistrant, B.D.; Moon, J.R.; Berkman, L.F.; Glymour, M.M. Current and long-term spousal caregiving and onset of cardiovascular disease. J. Epidemiol. Commun. Health 2012, 66, 951–956. [Google Scholar] [CrossRef]
  25. Capistrant, B.D. Caregiving for Older Adults and the Caregivers’ Health: An Epidemiologic Review. Curr. Epidemiol. Rep. 2016, 3, 72–80. [Google Scholar] [CrossRef]
  26. Schulz, R.; Beach, S.R.; Czaja, S.J.; Martire, L.M.; Monin, J.K. Family Caregiving for Older Adults. Annu. Rev. Psychol. 2020, 71, 635–659. [Google Scholar] [CrossRef]
  27. Peters, A.; Schweiger, U.; Pellerin, L.; Hubold, C.; Oltmanns, K.M.; Conrad, M.; Schultes, B.; Born, J.; Fehm, H. The selfish brain: Competition for energy resources. Neurosci. Biobehav. Rev. 2004, 28, 143–180. [Google Scholar] [CrossRef]
  28. Peters, A.; McEwen, B.S. Stress habituation, body shape and cardiovascular mortality. Neurosci. Biobehav. Rev. 2015, 56, 139–150. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Peters, A. The selfish brain: Competition for energy resources. Am. J. Hum. Biol. 2011, 23, 29–34. [Google Scholar] [CrossRef] [PubMed]
  30. Peters, A.; Kubera, B.; Hubold, C.; Langemann, D. The selfish brain: Stress and eating behavior. Front. Neurosci. 2011, 5, 74. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Peters, A.; McEwen, B.S.; Friston, K. Uncertainty and stress: Why it causes diseases and how it is mastered by the brain. Prog. Neurobiol. 2017, 156, 164–188. [Google Scholar] [CrossRef]
  32. Kubera, B.; Leonhard, C.; Rößler, A.; Peters, A. Stress-Related Changes in Body Form: Results from the Whitehall II Study. Obesity 2017, 25, 1625–1632. [Google Scholar] [CrossRef] [Green Version]
  33. Kirschbaum, C.; Prüssner, J.C.; Stone, A.A.; Federenko, I.; Gaab, J.; Lintz, D.; Schommer, N.; Hellhammer, D. Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychosom. Med. 1995, 57, 468–474. [Google Scholar] [CrossRef]
  34. Xu, X.; Bao, H.; Strait, K.; Spertus, J.A.; Lichtman, J.H.; D’Onofrio, G.; Spatz, E.; Bucholz, E.M.; Geda, M.; Lorenze, N.P.; et al. Sex differences in perceived stress and early recovery in young and middle-aged patients with acute myocardial infarction. Circulation 2015, 131, 614–623. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Epel, E.S.; McEwen, B.; Seeman, T.; Matthews, K.; Castellazzo, G.; Brownell, K.D.; Bell, J.; Ickovics, J.R. Stress and Body Shape: Stress-Induced Cortisol Secretion Is Consistently Greater Among Women With Central Fat. Psychosom. Med. 2000, 62, 623–632. [Google Scholar] [CrossRef] [PubMed]
  36. Aschbacher, K.; Kornfeld, S.; Picard, M.; Puterman, E.; Havel, P.J.; Stanhope, K.; Lustig, R.H.; Epel, E. Chronic stress increases vulnerability to diet-related abdominal fat, oxidative stress, and metabolic risk. Psychoneuroendocrinology 2014, 46, 14–22. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Björntorp, P.; Rosmond, R. Neuroendocrine abnormalities in visceral obesity. Int. J. Obes. 2000, 24, S80–S85. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Tomiyama, A.J. Stress and Obesity. Annu. Rev. Psychol. 2019, 70, 703–718. [Google Scholar] [CrossRef] [Green Version]
  39. Schaeuble, D.; Packard, A.E.B.; McKlveen, J.M.; Morano, R.; Fourman, S.; Smith, B.L.; Scheimann, J.R.; Packard, B.A.; Wilson, S.P.; James, J.; et al. Prefrontal Cortex Regulates Chronic Stress-Induced Cardiovascular Susceptibility. J. Am. Heart Assoc. 2019, 8, e014451. [Google Scholar] [CrossRef] [PubMed]
  40. Van Rossum, E.F.C. Obesity and cortisol: New perspectives on an old theme. Obesity 2017, 25, 500–501. [Google Scholar] [CrossRef]
  41. Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.; Krauss, R.M.; Savage, P.J.; Smith, S.C.; et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112, 2735–2752. [Google Scholar] [CrossRef] [Green Version]
  42. Huang, X.; Liu, X.; Yu, Y. Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms? Front. Mol. Neurosci. 2017, 10, 134. [Google Scholar] [CrossRef] [Green Version]
  43. Von Känel, R.; Abbas, C.C.; Begré, S.; Gander, M.-L.; Saner, H.; Schmid, J.-P. Association between posttraumatic stress disorder following myocardial infarction and liver enzyme levels: A prospective study. Dig. Dis. Sci. 2010, 55, 2614–2623. [Google Scholar] [CrossRef] [Green Version]
  44. Stefan, N.; Kantartzis, K.; Machann, J.; Schick, F.; Thamer, C.; Rittig, K.; Balletshofer, B.; Machicao, F.; Fritsche, A.; Häring, H.U. Identification and Characterization of Metabolically Benign Obesity in Humans. Arch. Intern. Med. 2008, 168, 1609–1616. [Google Scholar] [CrossRef] [PubMed]
  45. Wildman, R.P.; Muntner, P.; Reynolds, K. The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering: Prevalence and Correlates of 2 Phenotypes Among the US Population (NHANES 1999–2004). Arch. Intern. Med. 2008, 168, 1617–1624. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Blüher, M. Metabolically Healthy Obesity. Endocr. Rev. 2020, 41, 405–420. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Stefan, N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol. 2020, 8, 616–627. [Google Scholar] [CrossRef]
  48. Carver, C.S.; Scheier, M.F.; Weintraub, J.K. Assessing Coping Strategies: A Theoretically Based Approach. J. Personal. Soc. Psychol. 1989, 56, 267–283. [Google Scholar] [CrossRef]
  49. Lazarus, R.S. The psychology of stress and coping. Issues Ment. Health Nurs. 1985, 7, 399–418. [Google Scholar] [CrossRef] [PubMed]
  50. Taylor, S.E.; Stanton, A.L. Coping resources, coping processes, and mental health. Annu. Rev. Clin. Psychol. 2007, 3, 377–401. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. Azizi, M. Effects of Doing Physical Exercises on Stress-Coping Strategies and the Intensity of the Stress Experienced by University Students in Zabol, Southeastern Iran. Proc. Soc. Behav. Sci. 2011, 30, 372–375. [Google Scholar] [CrossRef] [Green Version]
  52. Armborst, D.; Metzner, C.; Alteheld, B.; Bitterlich, N.; Rösler, D.; Siener, R. Impact of a Specific Amino Acid Composition with Micronutrients on Well-Being in Subjects with Chronic Psychological Stress and Exhaustion Conditions: A Pilot Study. Nutrients 2018, 10, 551. [Google Scholar] [CrossRef] [Green Version]
  53. Kocalevent, R.-D.; Hinz, A.; Brähler, E.; Klapp, B.F. Regionale und individuelle Faktoren von Stresserleben in Deutschland: Ergebnisse einer repräsentativen Befragung mit dem Perceived Stress Questionnaire (PSQ). Gesundheitswesen 2011, 73, 829–834. [Google Scholar] [CrossRef]
  54. Schneider, H.; Wall, H.; Zeller, H.J. The psychologiconeurological questionnaire—A screeining method for examinations of ability and control. Z. fur Klin. Med.-ZKM 1988, 43, 1321–1322. [Google Scholar]
  55. Schneiderman, N.; Ironson, G.; Siegel, S.D. Stress and health: Psychological, behavioral, and biological determinants. Annu. Rev. Clin. Psychol. 2005, 1, 607–628. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Bergmann, N.; Gyntelberg, F.; Faber, J. The appraisal of chronic stress and the development of the metabolic syndrome: A systematic review of prospective cohort studies. Endocr. Connect. 2014, 3, R55–R80. [Google Scholar] [CrossRef] [PubMed]
  57. Hassoun, L.; Herrmann-Lingen, C.; Hapke, U.; Neuhauser, H.; Scheidt-Nave, C.; Meyer, T. Association between chronic stress and blood pressure: Findings from the German Health Interview and Examination Survey for Adults 2008-2011. Psychosom. Med. 2015, 77, 575–582. [Google Scholar] [CrossRef] [PubMed]
  58. Roy, B.; Riley, C.; Sinha, R. Emotion regulation moderates the association between chronic stress and cardiovascular disease risk in humans: A cross-sectional study. Stress 2018, 21, 548–555. [Google Scholar] [CrossRef] [PubMed]
  59. Björntorp, P. Do stress reactions cause abdominal obesity and comorbidities? Obes. Rev. 2001, 2, 73–86. [Google Scholar] [CrossRef]
  60. Peters, A.; Kubera, B.; Hubold, C.; Langemann, D. The corpulent phenotype-how the brain maximizes survival in stressful environments. Front. Syst. Neurosci. 2013, 7, 47. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Kuo, L.E.; Kitlinska, J.B.; Tilan, J.U.; Li, L.; Baker, S.B.; Johnson, M.D.; Lee, E.W.; Burnett, M.S.; Fricke, S.T.; Kvetnansky, R.; et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat. Med. 2007, 13, 803–811. [Google Scholar] [CrossRef]
  62. Hirsch, D.; Zukowska, Z. NPY and stress 30 years later: The peripheral view. Cell. Mol. Neurobiol. 2012, 32, 645–659. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Steptoe, A.; Wardle, J. Cardiovascular stress responsivity, body mass and abdominal adiposity. Int. J. Obes. 2005, 29, 1329–1337. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Stefan, N.; Häring, H.-U.; Hu, F.B.; Schulze, M.B. Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013, 1, 152–162. [Google Scholar] [CrossRef]
  65. Stefan, N.; Schick, F.; Häring, H.-U. Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans. Cell Metab. 2017, 26, 292–300. [Google Scholar] [CrossRef] [PubMed]
  66. Razzoli, M.; Bartolomucci, A. The Dichotomous Effect of Chronic Stress on Obesity. Trends Endocrinol. Metab. 2016, 27, 504–515. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Chávez-Castillo, M.; Martínez, M.S.; Calvo, M.J.; Rojas, M.; Núñez, V.; Lameda, V.A.; Ramírez, P.; Rojas-Quintero, J.; Velasco, M.; Bermúdez, V. Chronic State of Systemic Stress: The Link between Depression and Cardiovascular Disease? SM J. Clin. Med. 2017, 3, 2–7. [Google Scholar]
  68. Dallman, M.F.; Pecoraro, N.; Akana, S.F.; la Fleur, S.E.; Gomez, F.; Houshyar, H.; Bell, M.E.; Bhatnagar, S.; Laugero, K.D.; Manalo, S. Chronic stress and obesity: A new view of “comfort food”. Proc. Natl. Acad. Sci. USA 2003, 100, 11696–11701. [Google Scholar] [CrossRef] [Green Version]
  69. Sominsky, L.; Spencer, S.J. Eating behavior and stress: A pathway to obesity. Front. Psychol. 2014, 5, 1–8. [Google Scholar] [CrossRef] [PubMed]
  70. Mensink, G.B.M.; Schienkiewitz, A.; Haftenberger, M.; Lampert, T.; Ziese, T.; Scheidt-Nave, C. Übergewicht und Adipositas in Deutschland: Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsblatt 2013, 56, 786–794. [Google Scholar] [CrossRef] [Green Version]
  71. Fahrngruber-Velasquez, C.; Duszka, K.; König, J. The Impact of Chronic Stress and Eating Concern on Acylated Ghrelin Following Acute Psychological Stress in Healthy Men. Stresses 2021, 1, 3. [Google Scholar] [CrossRef]
  72. Richardson, A.S.; Arsenault, J.E.; Cates, S.C.; Muth, M.K. Perceived stress, unhealthy eating behaviors, and severe obesity in low-income women. Nutr. J. 2015, 14, 122. [Google Scholar] [CrossRef] [Green Version]
  73. Geschwind, N.; Peeters, F.; Jacobs, N.; Delespaul, P.; Derom, C.; Thiery, E.; van Os, J.; Wichers, M. Meeting risk with resilience: High daily life reward experience preserves mental health. Acta Psychiatr. Scand. 2010, 122, 129–138. [Google Scholar] [CrossRef]
  74. Lawless, M.H.; Harrison, K.A.; Grandits, G.A.; Eberly, L.E.; Allen, S.S. Perceived stress and smoking-related behaviors and symptomatology in male and female smokers. Addict. Behav. 2015, 51, 80–83. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Balkan, B.; Pogun, S. Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides During the Stress Response. Curr Neuropharmacol. 2018, 16, 371–387. [Google Scholar] [CrossRef] [PubMed]
  76. Virani, S.S.; Alonso, A.; Benjamin, E.J.; Bittencourt, M.S.; Callaway, C.W.; Carson, A.P.; Chamberlain, A.M.; Chang, A.R.; Cheng, S.; Delling, F.N.; et al. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation 2020, 141, e139–e596. [Google Scholar] [CrossRef] [PubMed]
  77. Caliri, A.W.; Tommasi, S.; Besaratinia, A. Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer. Mutat. Res. Mutat. Res. 2021, 787, 108365. [Google Scholar] [CrossRef] [PubMed]
  78. Schilling, R.; Colledge, F.; Ludyga, S.; Pühse, U.; Brand, S.; Gerber, M. Does Cardiorespiratory Fitness Moderate the Association between Occupational Stress, Cardiovascular Risk, and Mental Health in Police Officers? Int. J. Environ. Res. Public Health 2019, 16, 2349. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. Kandola, A.; Ashdown-Franks, G.; Hendrikse, J.; Sabiston, C.M.; Stubbs, B. Physical activity and depression: Towards understanding the antidepressant mechanisms of physical activity. Neurosci. Biobehav. Rev. 2019, 107, 525–539. [Google Scholar] [CrossRef]
  80. Schultz, N.S.; Chui, K.K.H.; Economos, C.D.; Lichtenstein, A.H.; Volpe, S.L.; Sacheck, J.M. Impact of physical activity, diet quality and stress on cardiometabolic health in school employees. Prev. Med. Rep. 2020, 20, 101243. [Google Scholar] [CrossRef]
  81. Stults-Kolehmainen, M.A.; Sinha, R. The effects of stress on physical activity and exercise. Sports Med. 2014, 44, 81–121. [Google Scholar] [CrossRef]
  82. Colberg, S.R.; Sigal, R.J.; Yardley, J.E.; Riddell, M.C.; Dunstan, D.W.; Dempsey, P.C.; Horton, E.S.; Castorino, K.; Tate, D.F. Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016, 39, 2065–2079. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Reimers, A.K.; Knapp, G.; Reimers, C.-D. Effects of Exercise on the Resting Heart Rate: A Systematic Review and Meta-Analysis of Interventional Studies. J. Clin. Med. 2018, 7, 503. [Google Scholar] [CrossRef] [Green Version]
  84. Zhang, D.; Shen, X.; Qi, X. Resting heart rate and all-cause and cardiovascular mortality in the general population: A meta-analysis. Can. Med Assoc. J. 2016, 188, E53–E63. [Google Scholar] [CrossRef] [Green Version]
  85. Ruiz-Ramie, J.J.; Barber, J.L.; Sarzynski, M.A. Effects of exercise on HDL functionality. Curr. Opin. Lipidol. 2019, 30, 16–23. [Google Scholar] [CrossRef] [PubMed]
  86. Zhang, S.; Ma, C.; Wang, X.; Wang, Q.; Song, W.; Li, C.; Zhai, C.; Qi, Y.; Fan, S.; Cheng, F. Impact of chronic psychological stress on nonalcoholic fatty liver disease. Int. J. Clin. Exp. Med. 2019, 12, 7991–7998. [Google Scholar]
  87. Kang, D.; Zhao, D.; Ryu, S.; Guallar, E.; Cho, J.; Lazo, M.; Shin, H.; Chang, Y.; Sung, E. Perceived stress and non-alcoholic fatty liver disease in apparently healthy men and women. Sci. Rep. 2020, 10, 38. [Google Scholar] [CrossRef]
  88. Madhu, S.V.; Siddiqui, A.; Desai, N.G.; Sharma, S.B.; Bansal, A.K. Chronic stress, sense of coherence and risk of type 2 diabetes mellitus. Diabetol. Metab. Syndr. 2019, 13, 18–23. [Google Scholar] [CrossRef] [PubMed]
  89. Sirois, F.M.; Molnar, D.S.; Hirsch, J.K. Self-Compassion, Stress, and Coping in the Context of Chronic Illness. Self Identity 2014, 14, 334–347. [Google Scholar] [CrossRef] [Green Version]
  90. McEwen, B.S. In pursuit of resilience: Stress, epigenetics, and brain plasticity. Ann. N. Y. Acad. Sci. 2016, 1373, 56–64. [Google Scholar] [CrossRef]
  91. Gouin, J.-P.; Glaser, R.; Malarkey, W.B.; Beversdorf, D.; Kiecolt-Glaser, J. Chronic stress, daily stressors, and circulating inflammatory markers. Health Psychol. 2012, 31, 264–268. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  92. Maggio, M.; Guralnik, J.M.; Longo, D.L.; Ferrucci, L. Interleukin-6 in Aging and Chronic Disease: A Magnificent Pathway. J. Gerontol. 2006, 61, 575–584. [Google Scholar] [CrossRef] [PubMed]
  93. Wium-Andersen, M.K.; Ørsted, D.D.; Nielsen, S.F.; Nordestgaard, B.G. Elevated C-reactive protein levels, psychological distress, and depression in 73 131 individuals. JAMA Psychiatry 2013, 70, 176–184. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Marques-Vidal, P.; Bastardot, F.; von Känel, R.; Paccaud, F.; Preisig, M.; Waeber, G.; Vollenweider, P. Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study). Clin. Endocrinol. 2013, 78, 232–241. [Google Scholar] [CrossRef] [PubMed]
  95. Johnson, T.V.; Abbasi, A.; Master, V.A. Systematic review of the evidence of a relationship between chronic psychosocial stress and C-reactive protein. Mol. Diagn. Ther. 2013, 17, 147–164. [Google Scholar] [CrossRef]
  96. Lee, S.J.; Oh, B.K.; Sung, K.-C. Uric acid and cardiometabolic diseases. Clin. Hypertens. 2020, 26, 2–7. [Google Scholar] [CrossRef] [PubMed]
  97. Sharaf El Din, U.A.A.; Salem, M.M.; Abdulazim, D.O. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. J. Adv. Res. 2017, 8, 537–548. [Google Scholar] [CrossRef]
  98. Yuan, H.; Yu, C.; Li, X.; Sun, L.; Zhu, X.; Zhao, C.; Zhang, Z.; Yang, Z. Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies. J. Clin. Endocrinol. Metab. 2015, 100, 4198–4207. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  99. Nieto, F.J.; Iribarren, C.; Gross, M.D.; Comstock, G.W.; Cutler, R.G. Uric acid and serum antioxidant capacity: A reaction to atherosclerosis? Atherosclerosis 2000, 148, 131–139. [Google Scholar] [CrossRef]
  100. Joshi, R.; Adhikari, S.; Patro, B.S.; Chattopadhyay, S.; Mukherjee, T. Free radical scavenging behavior of folic acid: Evidence for possible antioxidant activity. Free Radic. Biol. Med. 2001, 30, 1390–1399. [Google Scholar] [CrossRef]
  101. Neeland, I.J.; Ross, R.; Després, J.-P.; Matsuzawa, Y.; Yamashita, S.; Shai, I.; Seidell, J.; Magni, P.; Santos, R.D.; Arsenault, B.; et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: A position statement. Lancet Diabetes Endocrinol. 2019, 7, 715–725. [Google Scholar] [CrossRef]
  102. Iqbal, U.; Perumpail, B.J.; Akhtar, D.; Kim, D.; Ahmed, A. The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. Medicines 2019, 6, 41. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Ho, J.S.; Cannaday, J.J.; Barlow, C.E.; Mitchell, T.L.; Cooper, K.H.; FitzGerald, S.J. Relation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortality. Am. J. Cardiol. 2008, 102, 689–692. [Google Scholar] [CrossRef] [PubMed]
  104. Kuo, W.-C.; Bratzke, L.C.; Oakley, L.D.; Kuo, F.; Wang, H.; Brown, R.L. The association between psychological stress and metabolic syndrome: A systematic review and meta-analysis. Obes. Rev. 2019, 20, 1651–1664. [Google Scholar] [CrossRef] [PubMed]
Nutrients 14 00077 g001 550
Figure 1. The relationship of the chronic perceived stress load and the cardiometabolic risk in the ITT population. The relationships between the total PSQ30 score (independent variable) and the dependent variables (a) fatty liver index, (b) LDL-C/HDL-C quotient and (c) insulin concentration were examined. Results for the high stress (HS) group (n = 31), the very high stress (VHS) group (n = 30), and the cut-off value (dashed line) for FLI and LDL-C/HDL-C quotient are shown. Regression lines: (a) Beta value = −0.266, p = 0.038, 95% confidence interval: −125.1 to −3.7; (b) Beta value = −0.294, p = 0.022, 95% confidence interval: −4.5 to −0.4; (c) Beta value = −0.330, p = 0.009, 95% confidence interval: −20.6 to −3.0.
Figure 1. The relationship of the chronic perceived stress load and the cardiometabolic risk in the ITT population. The relationships between the total PSQ30 score (independent variable) and the dependent variables (a) fatty liver index, (b) LDL-C/HDL-C quotient and (c) insulin concentration were examined. Results for the high stress (HS) group (n = 31), the very high stress (VHS) group (n = 30), and the cut-off value (dashed line) for FLI and LDL-C/HDL-C quotient are shown. Regression lines: (a) Beta value = −0.266, p = 0.038, 95% confidence interval: −125.1 to −3.7; (b) Beta value = −0.294, p = 0.022, 95% confidence interval: −4.5 to −0.4; (c) Beta value = −0.330, p = 0.009, 95% confidence interval: −20.6 to −3.0.
Nutrients 14 00077 g001
Table
Table 1. Characteristics of participants.
Table 1. Characteristics of participants.
ITT Population
n = 61
Mean ± SD
n (%)		HS Group (1)
n = 31
Mean ± SD
n (%)		VHS Group (2)
n = 30
Mean ± SD
n (%)		HS vs. VHS
p Value
Age (years)44.6 ± 12.145.3 ± 12.143.7 ± 12.30.559
Women43 (70.5%)21 (67.7%)22 (73.3%)0.780
Men18 (29.5%)10 (32.3%)8 (26.7%)
Smokers 15 (24.6%)12 (38.7%)3 (10.0%)0.016
Total PSQ30 score0.671 ± 0.1180.573 ± 0.0570.771 ± 0.069<0.001
PNF (total)51.3 ± 12.146.2 ± 10.956.6 ± 11.2<0.001
Marital status (3):
Married/cohabitation 31 (50.8%)14 (45.2%)17 (56.7%)0.373
Single 17 (27.9%)11 (35.5%)6 (20.0%)
Separated 12 (19.7%)6 (19.4%)6 (20.0%)
Children (3):
0 children 32 (52.5%)16 (51.6%)16 (53.3%)0.445
1 child 15 (24.6%)10 (32.3%)5 (16.7%)
2 children 9 (14.8%)3 (9.7%)6 (20.0%)
≥3 children 4 (6.6%)2 (6.5%)2 (6.7%)
Care for a family member in need (4):
Yes 17 (27.9%)9 (29.0%)8 (26.7%)1.000
No42 (68.9%)21 (67.7%)21 (70.0%)
Work in shifts:
Yes14 (23.0%)6 (19.4%)8 (26.7%)0.554
No47 (77.0%)25 (80.6%)22 (73.3%)
Regular physical activity:
No14 (23.0%)10 (32.3%)4 (13.3%)0.127
Yes47 (77.0%)21 (67.7%)26 (86.7%)
Yes: athletic and endurance sports
(jogging, bicycling, swimming, fitness studio or horse-riding)		20 (32.8%)8 (25.8%)12 (41.4%)0.283
Yes: low-intensity endurance sports
(Nordic walking or going for a walk)		21 (34.4%)9 (29.0%)12 (40.0%)0.426
Yes: autogenous training or yoga6 (9.8%)4 (12.9%)2 (6.7%)0.671
Abbreviations: IIT, intention-to-treat population; PNF, Psychological Neurological Questionnaire; PSQ, Perceived Stress Questionnaire; SD, standard deviation. (1) High stress (HS) group: participants with a total PSQ30 score of 0.500–0.656; (2) Very high stress (VHS) group: participants with a total PSQ30 score > 0.656; (3) one person did not answer the question because of personal reasons; (4) two persons did not answer the question because of personal reasons; p Value: Mann–Whitney U test or Fisher’s exact test.
Table
Table 2. Cardiometabolic risk of participants.
Table 2. Cardiometabolic risk of participants.
ITT Population
n = 61
Mean ± SD
n (%)		HS Group (1)
n = 31
Mean ± SD
n (%)		VHS Group (2)
n = 30
Mean ± SD
n (%)		HS vs. VHS
p Value
Anthropometric and clinical parameters
BMI (kg/m2)25.5 ± 5.126.6 ± 6.024.4 ± 3.710.169
WC (cm)_women86.3 ± 12.489.7 ± 14.383.4 ± 9.440.079
WC (cm)_men101.7 ± 13.6106.1 ± 16.396.2 ± 6.670.051
BP systolic (mmHg)112.1 ± 14.2115.2 ± 14.7109.0 ± 13.10.094
BP diastolic (mmHg)75.2 ± 8.576.6 ± 8.773.7 ± 8.20.141
Resting heart rate (1/min)66.5 ± 8.566.2 ± 7.766.9 ± 9.50.906
Cardiometabolic risk parameters
BMI ≥ 30.0 kg/m211 (18.0%)8 (25.8%)3 (10.0%)0.182
WC ≥ 88 cm (w/≥ 102 cm (m))28 (45.9%)20 (64.5%)8 (26.7%)0.005
BP ≥ 130/85 mmHg11 (18.0%)9 (29.0%)2 (6.7%)0.043
TC (mg/dL)212.2 ± 46.9217.0 ± 45.4207.2 ± 48.80.372
TC > 200 35 (57.4%)21 (67.7%)14 (46.7%)0.124
HDL-C (mg/dL)64.7 ± 19.860.2 ± 17.169.4 ± 21.60.117
HDL-C < 50 (w)/< 40 (m)14 (23.0%)7 (22.6%)7 (23.3%)1.000
LDL-C (mg/dL)134.2 ± 41.6140.1 ± 39.4128.1 ± 43.60.261
LDL-C ≥ 175 11 (18.0%)6 (19.4%)5 (16.7%)1.000
TG (mg/dL)100.1 ± 53.7111.8 ± 68.488.1 ± 28.90.249
TG ≥ 1506 (9.8%)5 (16.1%)1 (3.3%)0.195
Fasting plasma glucose (mg/dL)89.7 ± 17.191.7 ± 22.287.7 ± 9.20.923
FPG ≥ 100 (mg/dL)7 (11.5%)5 (16.1%)2 (6.7%)0.425
HbA1c (%)5.5 ± 0.65.6 ± 0.75.4 ± 0.30.179
HOMA index1.7 ± 1.52.1 ± 2.01.3 ± 0.60.184
Insulin–ECLIA (μU/mL)7.3 ± 4.28.3 ± 4.96.2 ± 3.00.107
Metabolic syndrome (NCEP [41])6 (9.8%)6 (19.4%)0 (0%)0.024
ALAT (U/L)23.7 ± 12.024.94 ± 12.822.5 ± 11.10.540
ASAT (U/L)25.2 ± 12.626.8 ± 17.223.5 ± 4.10.860
FLI33.5 ± 28.442.5 ± 31.924.1 ± 21.10.045
FLI ≥ 3028 (45.9%)19 (61.3%)9 (30.0%)0.021
FLI ≥ 6014 (23.0%)10 (32.3%)4 (13.3%)0.127
Atherogenic dyslipoproteinemia3 (4.9%)3 (9.7%)0 (0%)0.238
TC/HDL-C3.5 ± 1.23.9 ± 1.43.2 ± 0.90.022
LDL-C/HDL-C2.3 ± 1.02.5 ± 1.02.0 ± 0.80.030
Serum serotonin and salivary cortisol
Serum serotonin (μg/L)144.3 ± 69.2135.4 ± 47.8153.4 ± 85.80.734
Cortisol_morning (ng/mL)13.8 ± 5.714.0 ± 6.013.6 ± 5.50.783
Cortisol_evening (ng/mL)2.5 ± 3.82.7 ± 3.72.3 ± 3.90.544
Δ cortisol (m–e) (ng/mL)11.3 ± 6.011.3 ± 6.911.3 ± 5.10.997
Oxidative stress markers and antioxidative status
CRP sensitive (mg/L)2.2 ± 3.42.0 ± 2.92.4 ± 3.90.821
Ferritin (ng/mL)114.9 ± 106.9116.6 ± 132.5113.1 ± 74.20.458
GGT (U/L)22.2 ± 13.225.1 ± 15.019.3 ± 10.60.142
Folic acid (ng/mL) (3)9.6 ± 3.69.4 ± 3.89.8 ± 3.40.438
Uric acid (mg/dL)4.8 ± 1.15.0 ± 1.14.6 ± 1.10.179
Abbreviations: ALAT, alanine aminotransferase; ASAT, aspartate aminotransferase; BMI, body mass index; BP, blood pressure; Δ cortisol (m–e), cortisol difference morning–evening; CRP, C-reactive protein; ECLIA, electrochemiluminescence immunoassay; FLI, fatty liver index; FPG, fasting plasma glucose; GGT, gamma-glutamyltransferase; HbA1c, glycated hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HOMA index, homeostasis model assessment index; ITT, intention-to-treat population; LDL-C, low-density lipoprotein cholesterol; NCEP, National Cholesterol Education Program; SD, standard deviation; TC, total cholesterol; TG, triglycerides; WC, waist circumference. (1) High stress (HS) group: participants with a total PSQ30 score of 0.500–0.656; (2) Very high stress (VHS) group: participants with a total PSQ30 score > 0.656; (3) n = 60, data not available for one participant (hemolytic blood sample); p Value: Mann–Whitney U test or Fisher’s exact test.
Table
Table 3. Relationship of cardiometabolic risk parameters and in-/direct markers of inflammation and oxidative stress (age adjusted).
Table 3. Relationship of cardiometabolic risk parameters and in-/direct markers of inflammation and oxidative stress (age adjusted).
CRP
(mg/L)		Uric Acid
(mg/dL)		FLI
ITT
Population		HS Group (1)VHS Group (2)ITT
Population		HS Group (1)VHS Group (2)ITT
Population		HS Group (1)VHS Group (2)
RCBp ValueRCBp ValueRCBp ValueRCBp ValueRCBp ValueRCBp ValueRCBp ValueRCBp ValueRCBp Value
Weight (kg)0.0540.0330.0540.0570.0730.1600.038<0.0010.0360.0010.0400.0031.366<0.0011.298<0.0011.255<0.001
WC (cm)0.0660.0450.0810.0220.0720.3280.039<0.0010.0360.0100.0450.0201.805<0.0011.720<0.0011.722<0.001
BMI (kg/m2)0.2040.0200.1850.0520.3700.0720.0900.0010.0820.0290.1010.0704.694<0.0014.228<0.0015.053<0.001
Syst. BD (mmHg)0.0190.568−0.0100.8100.0550.3420.036<0.0010.0190.2620.052<0.0010.8340.0010.5130.2160.7260.014
Diast. BD (mmHg)0.0580.2770.0090.8940.1210.1890.0410.0170.0110.6890.0650.0061.428<0.0011.0890.0861.2490.008
Heart rate (1/min)0.1080.0380.0030.9650.1800.0210.0120.4970.0040.8900.0160.4660.8120.0491.1790.0840.4260.326
Insulin (μU/mL)0.2790.0070.1580.1570.7790.0010.0950.0050.0910.0360.0820.2453.738<0.0013.773<0.0011.5240.271
HOMA index0.4940.0880.2830.2943.4950.0020.2500.0070.2020.0540.5090.1189.889<0.0018.583<0.0018.5550.184
FPG (mg/dL)0.0170.5270.0160.5300.0380.6700.0220.0130.0170.0770.0430.0720.801<0.0010.767<0.0010.6190.190
HbA1c (%)0.4540.5720.3730.6132.4470.4510.4370.0930.2740.3451.7030.04617.6330.00415.3680.02527.9700.100
TG (mg/dL)0.0270.0010.031<0.0010.0320.2230.0070.0060.0060.0760.0130.0750.290<0.0010.2260.0030.3540.008
HDL-C (mg/dL)−0.0660.004−0.0860.004−0.0680.073−0.029<0.001−0.0220.079−0.0330.001−0.903<0.001−1.100<0.001−0.5480.005
Serotonin (μg/L)−0.0060.399−0.0150.214−0.0030.704−0.0050.029−0.0080.075−0.0030.199−0.1120.029−0.0820.492−0.0880.560
Vitamin E (mg)0.0610.3380.0290.7460.0760.4360.0290.1650.0240.5070.0340.1980.5120.3080.3740.6710.4260.417
Vitamin C (mg)0.0020.658−0.0050.6390.0040.5750.0010.3980.0020.6510.0020.3850.0290.486−0.0040.9650.0490.187
Folic acid (ng/mL) (3)−0.0490.705−0.2570.0760.2020.3860.0010.349−0.0170.7680.1200.0440.9800.3400.1400.9232.3970.043
PFA (g)−0.0130.8350.0160.864−0.0440.6440.0250.2060.0370.3040.0250.3290.4980.3080.5940.4990.4600.362
Vitamin B12 (µg)0.0340.7890.2670.100−0.1360.5110.0660.1140.1560.012−0.0220.6971.9170.0553.7140.015−0.0650.954
Total PSQ30 score−0.0080.998−1.9600.848−8.5740.439−1.9180.123−6.9430.0781.0490.729−63.950.032−102.20.29716.230.785
Abbreviations: BMI, body mass index; BP (syst./diast.), systolic or diastolic blood pressure; CRP, C-reactive protein sensitive; FLI, fatty liver index; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HOMA index, homeostasis model assessment index; (1) High stress (HS) group: participants with a total PSQ30 score of 0.500–0.656; (2) Very high stress (VHS) group: participants with a total PSQ30 score > 0.656. ITT, intention-to-treat population; PFA, polyunsaturated fatty acids; RCB, regression coefficient B; TG, triglycerides; WC, waist circumference. (3) n = 60, data not available for one participant (hemolytic blood sample); p value: linear regression analysis.
Table
Table 4. Coping strategies and cardiometabolic health of participants.
Table 4. Coping strategies and cardiometabolic health of participants.
ITT Population
Mean ± SD		HS Group (1)
Mean ± SD		VHS Group (2)
Mean ± SD
Coping strategy: ‘Allostatic load’ resulting in visceral adiposit
With
visceral
adiposity
n = 28		Without
visceral
adiposity
n = 33		p valueWith
visceral
adiposity
n = 20		Without
visceral
adiposity
n = 11		p valueWith
visceral
adiposity
n = 8		Without
visceral
adiposity
n = 22		p value
PSQ30 score0.619 ± 0.0930.714 ± 0.1200.0030.573 ± 0.0580.574 ± 0.0580.9920.735 ± 0.0530.784 ± 0.0700.072
FLI51.8 ± 25.817.9 ± 20.3<0.00156.1 ± 26.717.7 ± 25.5<0.00140.9 ± 21.218.1 ± 17.90.005
HOMA index2.3 ± 2.11.2 ± 0.50.0022.7 ± 2.30.9 ± 0.4<0.0011.4 ± 0.91.3 ± 0.50.738
HbA1c (%)5.7 ± 0.85.4 ± 0.30.0505.7 ± 0.95.5 ± 0.30.8305.6 ± 0.25.3 ± 0.30.034
CRP (mg/L)2.6 ± 3.61.8 ± 3.30.0242.1 ± 2.01.8 ± 4.20.0123.9 ± 6.01.8 ± 2.80.510
Coping strategy: Smoking
Smokers
n = 15		Non-
smokers
n = 46		p valueSmokers
n = 12		Non-
smokers
n = 19		p valueSmokers
n = 3		Non-
smokers
n = 27		p value
PSQ30 score0.602 ± 0.0910.693 ± 0.1180.0080.567 ± 0.0540.578 ± 0.0600.4370.744 ± 0.0620.774 ± 0.0700.563
HbA1c (%)5.7 ± 1.05.4 ± 0.30.6435.9 ± 1.15.4 ± 0.30.2705.1 ± 0.15.4 ± 0.30.024
Uric acid (mg/dL)4.8 ± 1.14.8 ± 1.10.9905.2 ± 1.04.9 ± 1.20.5153.4 ± 0.34.7 ± 1.10.031
CRP (mg/L)3.1 ± 3.81.9 ± 3.30.0913.5 ± 4.21.1 ± 0.80.0711.6 ± 1.22.5 ± 4.10.778
Coping strategy: Physical activity
With
physical
activity
n = 47		Without
physical
activity
n = 14		p valueWith
physical
activity
n = 21		Without
physical
activity
n = 10		p valueWith
physical
activity
n = 26		Without
physical
activity
n = 4		p value
PSQ30 score0.687 ± 0.1160.614 ± 0.1090.0390.581 ± 0.0580.558 ± 0.0520.3060.773 ± 0.0690.755 ± 0.0760.670
HbA1c (%)5.4 ± 0.35.8 ± 1.00.0605.4 ± 0.36.0 ± 1.20.1945.4 ± 0.35.5 ± 0.20.293
HDL-C (mg/dL)67.5 ± 17.455.2 ± 24.80.00664.5 ± 16.951.1 ± 14.30.03070.0 ± 17.765.4 ± 43.10.298
Resting heart rate (1/min)65.0 ± 8.571.6 ± 6.70.00863.6 ± 6.771.7 ± 6.80.00666.2 ± 9.771.3 ± 7.40.305
Abbreviations: CRP, C-reactive protein sensitive; FLI, fatty liver index; HbA1c, glycated hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HOMA index, homeostasis model assessment index; ITT, intention-to-treat population; PSQ, Perceived Stress Questionnaire; SD, standard deviation; (1) High stress group: participants with a total PSQ30 score of 0.500–0.656; (2) Very high stress group: participants with a total PSQ30 score > 0.656; p value: Mann–Whitney U test.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Armborst, D.; Bitterlich, N.; Alteheld, B.; Rösler, D.; Metzner, C.; Siener, R. Coping Strategies Influence Cardiometabolic Risk Factors in Chronic Psychological Stress: A Post Hoc Analysis of A Randomized Pilot Study. Nutrients 2022, 14, 77. https://doi.org/10.3390/nu14010077

AMA Style

Armborst D, Bitterlich N, Alteheld B, Rösler D, Metzner C, Siener R. Coping Strategies Influence Cardiometabolic Risk Factors in Chronic Psychological Stress: A Post Hoc Analysis of A Randomized Pilot Study. Nutrients. 2022; 14(1):77. https://doi.org/10.3390/nu14010077

Chicago/Turabian Style

Armborst, Deborah, Norman Bitterlich, Birgit Alteheld, Daniela Rösler, Christine Metzner, and Roswitha Siener. 2022. "Coping Strategies Influence Cardiometabolic Risk Factors in Chronic Psychological Stress: A Post Hoc Analysis of A Randomized Pilot Study" Nutrients 14, no. 1: 77. https://doi.org/10.3390/nu14010077

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop